Scott Alan Peslak MD PhD

PubMed

• 4 citations
  let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching.
  Peng Huang, Scott A Peslak, Vanessa Shehu, Cheryl A Keller, Belinda Giardine
  Blood. 2024-05-09
• Expansion of human hematopoietic stem cells by inhibiting translation.
  Chenchen Li, Hanna Shin, Dheeraj Bhavanasi, Mai Liu, Xiang Yu
  Biorxiv. 2023-11-29
• 11 citations
  Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts.
  Vera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, Natthakan Thongon, Guillermo Montalban-Bravo
  Blood Cancer Discovery. 2022-11-02

Abstracts/Posters

• Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes
  Scott A. Peslak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Heme-Regulated Inhibitor (HRI) Activates Transcription Factor ATF4 to Promote BCL11A Transcription and Fetal Hemoglobin Silencing
  Scott A. Peslak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Understanding Heterogeneity of Fetal Hemoglobin Induction through Comparative Analysis of Stage-Matched F- and a-Cells
  Scott A. Peslak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Heme-Regulated Inhibitor (HRI) Depletion Cooperates with Pharmacologic Inducers to Strongly Elevate Fetal Hemoglobin and Reduce Sickle Cell Formation 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019